Clinical, biochemical and immunological characteristics of asthma patients with concurrent hypertension
Abstract
77 asthma patients with co-morbid hypertension (main group) and 57 asthma patients without hypertension (comparison group) were examined. The biochemical and immunological rates characterizing the inflammation expression on the system and regional levels and state of lipid and carbohydrate exchange were examined as well as lipid peroxygenation-anti-oxidant protection system. In patients with co-morbid disorders the inflammation was more expressed and the connection between rates reflecting the expression of inflammation was found with the rates state of lipid and carbohydrate exchange of lipid peroxygenation-anti-oxidant protection system. It was found out that patients with co-morbid hypertension had lower health index and rarely achieved the full control over asthma.
About the Authors
T. N. Zaripova
Balneotherapy Research Institute
Russian Federation
Tomsk
Russian Federation
Tomsk
I. I. Аntipova
Balneotherapy Research Institute
Russian Federation
Tomsk
Russian Federation
Tomsk
References
1. Globalnaya strategiya lecheniya i profilaktiki bronkhialnoy astmy (GINA) [Global strategy for treatment and prevention of asthma.] Moscow, Atmoshera Publ., 2007, 103 p.
2. Demko I.V., Gordeeva N.V., Petrov M.M. et al. Symptoms and treatment of asthma with concurrent cardiac-vascular disorders. Bull. Sib. Med., 2007, no. 2, pp. 90-97. (In Russ.)
3. Dolya Е.М. Issues of pathogenesis and treatment of hypertension in asthma patients. Krym. Terapevt. J., 2014. no. 1. pp. 45-49. (In Russ.)
4. Zhdanov V.F. Sistemnaya arterial’naya gipertenziya u bol’nykh bronkhial’noy astmoy. Diss. dokt. med. nauk. [System hypertension in asthma patients. Doct. Diss.]. St. Petersburg, 1993, 40 p.
5. Zaripova T.N., Аntipova I.I., Smirnova I.N. et al. Clinical and functional specific features of asthma with concurrent hypertension. Bull. Sib. Med., 2009, no. 4, pp. 33-37. (In Russ.)
6. Zaripova T.N., Аntipova I.I., Smirnova I.N. Integral unified efficiency evaluation of using physical factors in the treatment of asthma patients. Sovr. Probl. Nauki i Obrazovaniya, 2015, no. 1:www.scince-education.ru/121-17994
7. Kozyrev A.G. Kliniko-funktsional’naya i biokhimicheskaya kharakteristika bol’nykh bronkhial’noy astmoy s sistemnoy arterial’noy gipertenziey Diss. kand. med. nauk. [Clinical, functional and biochemical characteristics of asthma patients with system hypertension. Cand. Diss.]. St. Petersburg, 2001, 15 p.
8. Roschina A.A. Аrterial’naya gipertenziya u bol’nykh bronkhial’noy astmoy: kliniko-funktsional’nye vzaimootnosheniya i vozmozhnosti medikamentoznoy korrektsii. Diss. kand. med. nauk. [Hypertension in asthma patients: clinical and functional relations and opportunities for medical management. Cand. Diss.]. Saratov, 2011, 25 p.
9. Spichkina V.L. Kliniko-funktsional’nye osobennosti techeniya arterial’noy gipertenzii u bol’nykh bronkhial’noy astmoy. Diss. kand. med. nauk. [Clinical and functional clinical course of hypertension in asthma patients. Cand. Diss.]. Ryazan, 2007, 24 p.
Review
For citations:
Zaripova T.N., Аntipova I.I. Clinical, biochemical and immunological characteristics of asthma patients with concurrent hypertension. Tuberculosis and Lung Diseases. 2016;94(2):36-41. (In Russ.)
Views:
606
Email this article 